Omega Therapeutics (OMGA)
(Delayed Data from NSDQ)
$1.98 USD
+0.02 (1.02%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.36 |
Last EPS Surprise | 5.26% |
ABR | 1.00 |
Earnings ESP
|
4.83% |
---|---|
Current Year | -1.30 |
Next Year | -1.19 |
EPS (TTM) | -1.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.68M | 0.68M | 4.86M | 2.97M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 0.85M | 0.85M | 5.80M | 4.00M |
Low Estimate | 0.50M | 0.50M | 3.86M | 1.50M |
Year ago Sales | 0.76M | 0.83M | 3.10M | 4.86M |
Year over Year Growth Est. | -11.18% | -18.67% | 56.90% | -38.92% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.31 | -1.30 | -1.19 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.40 | -0.33 | -1.37 | -1.19 |
High Estimate | -0.29 | -0.24 | -1.14 | -0.83 |
Low Estimate | -0.40 | -0.40 | -1.51 | -1.79 |
Year ago EPS | -0.54 | -0.40 | -1.80 | -1.30 |
Year over Year Growth Est. | 33.33% | 22.50% | 27.78% | 8.31% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 2 | 1 |
Up Last 60 Days | 2 | 2 | 3 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 2 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.31 | -1.30 | -1.19 |
7 Days Ago | -0.36 | -0.31 | -1.30 | -1.19 |
30 Days Ago | -0.35 | -0.30 | -1.29 | -1.24 |
60 Days Ago | -0.44 | -0.41 | -1.58 | -1.29 |
90 Days Ago | -0.44 | -0.44 | -1.85 | -1.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.27 | -1.24 | -1.04 |
Zacks Consensus Estimate | -0.36 | -0.31 | -1.30 | -1.19 |
Earnings ESP | 4.83% | 10.38% | 4.13% | 12.67% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -0.37 | -0.40 | -0.54 | NA |
Estimate | -0.38 | -0.46 | -0.56 | -0.51 | NA |
Difference | 0.02 | 0.09 | 0.16 | -0.03 | 0.06 |
Surprise | 5.26% | 19.57% | 28.57% | -5.88% | 11.88% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more